2011

Detecting the presence of inflammation in fibromyalgiasyndrome with neutrophil/lymphocyte ratio, platelet/ lymphocyte ratio, and mean platelet volume

Aim: Our purpose was to determine the presence of inflammation in Fibromyalgia Syndrome (FMS), whether the parameters ofneutrophil lymphocyte ratio (NLR) and platelet lymphocyte ratio (PLR) and mean platelet volume (MPV) can be used as inflammationmarkers. Materials and Methods: FMS patients who applied to Hatay State Hospital Physical Medicine and Rehabilitation Clinic in the lasttwo years were analyzed retrospectively from the patient records. 92 participants were enrolled in the study, 43 of them wereFMS patients, and 49 were healthy control group. Hemogram, glucose levels, hepatic panel and renal function tests, thyroid andparathyroid function testing, vitamin B12 and 25-hydroxyvitamin D, serum iron panel, folate, lipid panel, erythrocyte sedimentationrate (ESR), C-reactive protein, RF, Bucella agglutination test results were evaluated. Thus, patients with diseases that could affectNLR, PLR, and MPV were not enrolled in the study. Results: No significant difference between the groups in terms of gender distribution was found (p = 0.999). No significant differencebetween the groups in terms of age was found (p=0.327). When the groups were compared in terms of MPV, the values were found tobe lower in the FMS group. Statistically significant difference was not found in both groups in terms of NLR, PLR, White blood count(WBC) and Platelet (PLT) levels (p=0.106; p=0.710; p=0.271; p=0.141, respectively). Conclusion: A significant difference was not found in both groups in terms of NLR and PLR, which were thought to be inflammationmarkers. The statistically significant higher values of mean ESR values in the FMS group indicate that inflammation may be presentin the pathogenesis of FMS, but NLR and PLR cannot be used as indicators of inflammation, so correlating these rates with theseverity of symptoms would be meaningless.

PDF

___

1. Clauw DJ. Fibromyalgia: update on mechanisms and management. J Clin Rheumatol 2007;13:102-9.
2. Bennett RM, Friend R, Marcus Dawn et al. Criteria for the diagnosis of fibromyalgia: validation of the modified 2010 preliminary American College of Rheumatology criteria and the development of alternative criteria. Arthritis Care Res 2014;66: 1364-73.
3. Clauw DJ, Chrousos GP. Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuroimmunomodulation 1997;4:134-53.
4. Yunus MB. Fibromyalgia and overlapping disorders: the unifying concept of central sensitivity syndromes. Semin Arthritis Rheum 2007;36:339-56.
5. Reva CL, David TF, Charles G, et al. Helmick Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 2008;58:26-35.
6. Lippi G, Targher G, Martina Montagnana, et al. Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med 2009;133:628-32.
7. Proctor MJ, Morrison DS, Talwar D et al. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study. Eur J Cancer 2011;47:2633-41.
8. Ilgün E, Akyurek O, Kalkan AO, et al. Neutrophil/ Lymphocyte Ratio and Platelet/Lymphocyte Ratio in Fibromyalgia. Eur J Gen Med 2016;13:100-4.
9. Bath Philip, Algert C, Chapman N, et al. Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease. Stroke 2004;35:622-6.
10. Gur A , Karakoc M, Nas K, et al. Cytokines and depression in cases with fibromyalgia. J Rheumatol 2002;29:358-61.
11. Karabas C. Evaluation of neutrophil/lymphocyte ratio, platelet/lymphocyte ratio and mean platelet volume in patients of fibromyalgia. JAMER 2018;3:1-10.
12. Boyraz I, Karakoyun A, Koc Bunyamin. Determination presence of inflammation with neutrophil/lymphocyte and platelet /lymphocyte ratios in Fibromyalgia Syndrome. Europan J Health Sci 2015;1:15-9.
13. Kilic E, Rezvani A, Toprak AE, et al. Evaluation of Neutrophil to Lymphocyte and Platelet to Lymphocyte Ratios in Rheumatoid Arthritis. Dicle Med J 2016;43:241-7.
14. Atar E, Askin A. Evaluation of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and mean platelet volume in patients with knee osteoarthritis. Cukurova Med J 2017;42:353-60.
15. Kapsoritakis AN, Koukourakis MI, Sfiridaki A, et al. Mean platelet volume: a useful marker of inflammatory bowel disease activity. Am J Gastroenterol 2001;96: p. 776-81.
16. Yazici S, Yazici M, Erer B, et al. The platelet indices in patients with rheumatoid arthritis: mean platelet volume reflects disease activity. Platelets 2010;21: 122-5.